Quick Answer
AVITA Medical, Inc. reported Total Assets of $56.39 million for the year ending 2025.
- AVITA Medical, Inc. showed a decrease of -29.3% in Total Assets from 2024 to 2025.
- This data is from AVITA Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $75.42 million | Q4 2020: $69.31 million | Q1 2021: $128.09 million | Q3 2021: $121.17 million | Q1 2022: $106.49 million | Q2 2022: $102.67 million | Q3 2022: $99.93 million | Q1 2023: $92.62 million | Q2 2023: $86.33 million | Q3 2023: $81.01 million | Q1 2024: $97.38 million | Q2 2024: $87.83 million | Q3 2024: $81.05 million | Q1 2025: $69.56 million | Q2 2025: $58.13 million | Q3 2025: $63.73 million.
- Over the full 8 years of available data (2019 to 2025), AVITA Medical, Inc.'s Total Assets has grown by 118.7%.
- Historical annual values: Fiscal year 2025: $56.39 million | Fiscal year 2024: $79.71 million | Fiscal year 2023: $111.64 million | Fiscal year 2022: $98.26 million | Fiscal year 2021: $116.02 million | Fiscal year 2021: $125.50 million | Fiscal year 2020: $82.46 million | Fiscal year 2019: $25.78 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: